Novinyo Serge Amega is a seasoned Medical Affairs professional and the visionary President and Founder of Coral Pharma Consulting, LLC. With a robust background in multi-therapeutic areas, Novinyo has honed his expertise in medical information, publication strategy, and professional education, making significant contributions to the...
Novinyo Serge Amega is a seasoned Medical Affairs professional and the visionary President and Founder of Coral Pharma Consulting, LLC. With a robust background in multi-therapeutic areas, Novinyo has honed his expertise in medical information, publication strategy, and professional education, making significant contributions to the pharmaceutical and biotech industries. His extensive experience encompasses pivotal roles in phase III and IV clinical trials, where he has effectively collaborated with cross-functional teams to drive successful outcomes.
At Coral Pharma Consulting, Novinyo leads a dynamic team dedicated to providing comprehensive consulting services tailored to the unique needs of pharmaceutical companies, biotech firms, and clinical research organizations. His deep understanding of drug and device development, particularly in cardiovascular, endocrinology, and gastroenterology, positions him as a trusted advisor in the medical affairs landscape. Key projects under his leadership include the development of operating plans, lifecycle management strategies, and the implementation of effective field force training programs.
Novinyo’s problem-solving acumen is complemented by his ability to enhance internal processes, ensuring that clients achieve their strategic objectives efficiently. He is adept at facilitating key opinion leader interactions, conducting promotional and non-promotional reviews, and organizing advisory boards and investigators’ meetings. His commitment to excellence is evident in his approach to medical research and health economics, where he leverages his skills in dyslipidemia, oncology, and neurology to deliver impactful insights. Through Coral Pharma Consulting, Novinyo Serge Amega continues to shape the future of medical affairs, driving innovation and fostering collaboration across the healthcare ecosystem.
